Vanda Contests FDA Rejection of Gastroparesis Drug, Slams ‘Delayed’ Decision

Vanda Pharmaceuticals on Thursday announced that the regulator declined to approve its application, a decision the company says was delayed by more than 185 days and failed to satisfy the requirements of the Federal Drug and Cosmetic Act.